Fast Five Quiz: COVID-19 Clinical Keys

Michael Stuart Bronze, MD

Disclosures

October 22, 2020

According to NIH guidelines, norepinephrine is recommended as the first-choice vasopressor. For adults with COVID-19 and refractory shock, low-dose corticosteroid therapy ("shock reversal") is recommended above no corticosteroid use.

For adults with COVID-19 and acute hypoxemic respiratory failure despite conventional oxygen therapy, the NIH recommends HFNC oxygen over NIPPV. In the absence of an indication for endotracheal intubation, a closely monitored trial of NIPPV is recommended for adults with COVID-19 and acute hypoxemic respiratory failure for whom HFNC is not available.

The NIH recommends against using awake prone positioning as a rescue therapy for refractory hypoxemia to avoid intubation in patients who otherwise require intubation and mechanical ventilation.

For critically ill patients with COVID-19 who have acute kidney injury and who develop indications for renal replacement therapy, the NIH recommends continuous renal replacement therapy (CRRT), if available. If CRRT is not available or not possible owing to limited resources, the NIH recommends prolonged intermittent renal replacement therapy rather than intermittent hemodialysis.

Read more about the treatment of COVID-19.

This Fast Five Quiz was excerpted and adapted from the Medscape Drugs & Diseases article Coronavirus Disease 2019 (COVID-19).

Follow Medscape on Facebook, Twitter, Instagram, and YouTube

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....